T cell clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restriction.
Peptides corresponding to the mutated regions of the oncoprotein p21 ras are immunogenic and capable of eliciting HLA class II-restricted T cell responses. Here we report studies on the fine specificity of four T lymphocyte clones (TLC) from a single donor, using various truncated peptides derived from the residues 6-19 of p21 ras and a panel of well-characterized HLA homozygous cells as antigen-presenting cells. Putative minimum peptides of nine or ten amino acids could be defined for each TLC. Two of the TLC recognized peptides presented by DR2, and the two others recognized peptides presented by DQ6. Some notable differences in the requirement for certain amino acids were seen between the DR- and DQ-restricted TLC. Thus, Ser at residue 17 was required for stimulation of the DQ6-but not the DR2-restricted TLC. Val at residue 8 was essential for stimulation of all TLC, whereas one of the DR2-restricted TLC also required Val at residue 7. Some peptides which were nonstimulatory were still capable of binding to DQ6 molecules in peptide competition experiments. The results may be of importance for potential immunotherapy of cancer where transforming ras oncoproteins are involved.
Gedde-Dahl
T
T
Institut of Transplantation Immunology, National Hospital, Oslo, Norway.
Fossum
B
B
Eriksen
J A
JA
Thorsby
E
E
Gaudernack
G
G
D000595:Amino Acid Sequence; D000938:Antigen-Presenting Cells / Q000276:immunology; D002478:Cells, Cultured; D002999:Clone Cells; D006681:HLA-D Antigens / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000276:immunology; D016283:Proto-Oncogene Proteins p21(ras) / Q000276:immunology*; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology*
D006681:HLA-D Antigens; D010455:Peptides; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)